Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release May 22 2026

· Issued by Alembic Pharmaceuticals Limited via NSE India

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-may-22-2026-4

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Levothyroxine Sodium Tablets USP".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases